A detailed history of Tejara Capital LTD transactions in Renalytix PLC stock. As of the latest transaction made, Tejara Capital LTD holds 500,394 shares of RNLX stock, worth $145,114. This represents 0.04% of its overall portfolio holdings.

Number of Shares
500,394
Previous 500,394 -0.0%
Holding current value
$145,114
Previous $430 Million 73.14%
% of portfolio
0.04%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.26 - $1.47 $26,000 - $147,000
100,000 Added 24.98%
500,394 $430 Million
Q3 2023

Nov 13, 2023

SELL
$1.51 - $4.01 $62,530 - $166,058
-41,411 Reduced 9.37%
400,394 $641 Million
Q2 2023

Aug 11, 2023

BUY
$2.0 - $2.92 $37,326 - $54,495
18,663 Added 4.41%
441,805 $1.29 Billion
Q1 2023

May 12, 2023

BUY
$1.93 - $3.72 $35,641 - $68,697
18,467 Added 4.56%
423,142 $1.02 Billion
Q4 2022

Feb 13, 2023

BUY
$1.17 - $2.21 $473,469 - $894,331
404,675 New
404,675 $757 Million

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $10.9M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.